WHO Declares Rare Ebola Outbreak in DR Congo a Global Emergency

What happened

The World Health Organization (WHO) has officially declared the Ebola outbreak in the Democratic Republic of Congo (DRC) a public health emergency of international concern. The virus has been spreading undetected for several weeks, primarily in regions destabilized by civil war, which has significantly hindered the ability of health workers to monitor and contain the pathogen. There are currently nearly 250 suspected cases and 80 recorded deaths.

What's new in this update

The emergency declaration follows confirmation that the virus has crossed international borders. Two cases have been identified in Uganda, one of which resulted in a fatality. Health officials from Imperial College London and the WHO warn that the outbreak was detected very late—the first known case appeared in late April—suggesting the actual scale of transmission is likely much larger than current figures indicate.

Key details

This specific outbreak is caused by the Bundibugyo species of Ebola, one of the rarest forms of the virus. Bundibugyo has only caused two previous outbreaks, in 2007 and 2012, and has a mortality rate of approximately 30%. Unlike more common strains, there are no approved vaccines or pharmaceutical treatments for Bundibugyo. Additionally, initial diagnostic tests in this outbreak returned false negatives, requiring more sophisticated laboratory equipment to identify the species.

Background and context

While the WHO's declaration reflects a need for international coordination, specialists clarify that this is not the start of a global pandemic similar to Covid-19. The risk to the wider world remains low; however, the threat to regional neighbors like Uganda, South Sudan, and Rwanda is high due to trade and travel links. Containment is further complicated by the ongoing civil war in the DRC, which limits access to affected populations.

What to watch next

Health organizations are pivoting to 'optimised supportive care' to manage symptoms and improve survival rates in the absence of approved drugs. International coordination will focus on rapid identification and isolation of new cases. Experts will also be watching to see if experimental vaccines can be fast-tracked or if the conflict in the DRC will continue to prevent a full-scale medical response.